Table 4.
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Approach | ||||
ODP | Ref | |||
RDP | 0.184 (0.125, 0.273) | < 0.001 | 0.265 (0.165, 0.425) | < 0.001 |
Age | 1.011 (1.000, 1.021) | 0.044 | 1.017 (1.002, 1.031) | 0.022 |
Sex | ||||
Male | Ref | |||
Female | 0.840 (0.602, 1.173) | 0.307 | ||
BMI | 0.968 (0.928, 1.009) | 0.125 | ||
ALB | 0.980 (0.948, 1.012) | 0.223 | ||
Abdominal surgery history | 1.090 (0.660, 1.798) | 0.737 | ||
ASA score | ||||
1 | Ref | |||
2 | 1.064 (0.739, 1.532) | 0.739 | ||
3 | 2.416 (0.895, 6.519) | 0.082 | ||
CA 19-9 (IU/L) | ||||
≤ 35 | Ref | |||
> 35 | 3.054 (1.339, 6.965) | 0.008 | 2.548 (1.015, 6.393) | 0.046 |
PV/SMV abutment | 3,265,018.587 (0.000, Inf) | 0.970 | ||
Tumor size | 1.439 (1.308, 1.584) | < 0.001 | 1.443 (1.289, 1.614) | < 0.001 |
Pathology | ||||
Cystic neoplasm | Ref | |||
Solid neoplasm (SPT and PNET) | 0.921 (0.642, 1.322) | 0.655 | 1.268 (0.812, 1.982) | 0.297 |
IPMN | 1.200 (0.696, 2.070) | 0.512 | 1.303 (0.681, 2.492) | 0.424 |
Inflammatory neoplasm | 5.500 (2.291, 13.203) | < 0.001 | 4.477 (1.692, 11.845) | 0.003 |
Others | 0.812 (0.415, 1.588) | 0.542 | 0.913 (0.402, 2.074) | 0.827 |
Tumor location | ||||
Tail | Ref | |||
Body–tail junction | 1.237 (0.807, 1.897) | 0.329 | 1.487 (0.886, 2.494) | 0.133 |
Body and neck | 1.449 (1.018, 2.063) | 0.040 | 1.692 (1.099, 2.607) | 0.017 |
Operative time | 1.008 (1.005, 1.011) | < 0.001 | 0.999 (0.995, 1.003) | 0.554 |
Estimated blood loss | 1.004 (1.003, 1.006) | < 0.001 | 1.003 (1.001, 1.004) | 0.001 |
P values < 0.05 indicate a significant difference between the two groups are given in bold